QualChoice is amending or implementing new policies. Please see the table below for a list of these policies and their effective dates.
Medical Policy Number
Medical Policy Name
Effective Date of Change
Description of Changes
AR.QC.CP.CPA.359
Tirzepatide (Zepbound) - Citizen’s Bank Only
1/11/2027
Per August SDC: updated redirection to preferred GLP-1 receptor
agonist therapies from “failure of three of the following” to “failure
of all of the following” for members with concurrent T2DM.
AR.QC.CP.CPA.352
Semaglutide (Wegovy)- FEHB & Citizen’s Bank Only
1/11/2027
Per August SDC: updated redirection to preferred GLP-1 receptor
agonist therapies from “failure of three of the following” to “failure of all of the following” for members with concurrent T2DM.
For questions about QualChoice Medical Coverage Policies, please contact your Provider Relations Representative at 800.235.7111 or 501.228.7111, Monday through Friday, 8:00 a.m. to 5:00 p.m.